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BACKGROUND: Nonsteroidal anti-inflammatory drugs are widely used in Brazil in spite of the known risks associated with
their use, but investigation of their side effects conducted in this country has been far from sufficient. This study investigates the
use of NSAIDs among patients undergoing upper endoscopy in the Hospital das Clínicas of the Federal University of Minas
Gerais and the association of this use with the endoscopic diagnosis of gastric erosions, gastric erosions with hematin pigmentation,
and gastric ulcer.
METHODS: The cross-sectional methodological approach was used; 533 patients aged 17 or older were interviewed, between
June and December, 2000. Data were submitted to bivariate and multivariate analyses.
RESULTS: More than two thirds of the interviewed population reported the use of nonsteroidal anti-inflammatory drugs in a
period of 1 month before the upper endoscopy. The most used nonsteroidal anti-inflammatory drugs were acetylsalicylic acid and
diclofenac. An association was clearly shown between the use of these drugs and the occurrence of the studied lesions, with the
latter attaining significance. There was also a significant association between nonsteroidal anti-inflammatory drugs use for a
period greater than 15 days and the occurrence of the gastric lesions, with a higher odds ratio than for the other comparisons.
CONCLUSIONS: The results suggest that nonsteroidal anti-inflammatory drugs have a significant association with the occurrence
of the gastric lesions and point to the need of further study of this issue in Brazil.
KEYWORDS: Pharmacoepidemiology. Nonsteroidal anti-inflammatory drugs. Upper endoscopy. Adverse drug reaction.
INTRODUCTION
Nonsteroidal anti-inflammatory drugs (NSAIDs) are
among the most widely used drugs around the world. In-
ternationally, many studies have reported important data
relating to the adverse gastroduodenal reactions to NSAIDs,
the main cause of morbidity and mortality associated with
their use.1-3
The adverse gastrointestinal reactions associated with
the use of NSAIDs represent about one fourth of all drug-
related adverse reactions. They can be grouped as causing
(i) symptoms (nausea, rash, dyspepsia, pain, anemia), (ii)
gastric lesions, such as gastric or duodenal ulcers, or (iii)
complications (hemorrhage or perforation of new ulcers or
pre-existing ones).1 In Spain and Italy, about 38% of the
hospital admissions due to bleeding caused by gastric or
duodenal ulcer are related to the use of NSAIDs.2 In Fin-
land, a study about the incidence of death related to the
use of drugs in a university hospital, reported that
gastrointestinal bleeding associated with the use of NSAIDs
was the third most frequent fatal adverse reaction.3
Epidemiological studies show the variability of the fac-
tors that can alter the risk of gastrointestinal complication
associated with the use of NSAIDs. This variability reflects
methodological differences, such as the study design, the
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pathology definitions, the patients’ ages, the dosage and the
duration of NSAID use, among others. Most studies have
shown that advanced age, a previous history of peptic ul-
cer, the simultaneous use of other NSAIDs, and the use of
anticoagulants and corticosteroid are the most relevant fac-
tors related to the increase in the occurrence of peptic ul-
cer and complications.2,4,5 Likely risk factors also include
infection by Helicobacter pylori and the ingestion of large
quantities of alcohol.
In Brazil, important aspects related to NSAIDs are the
fact of their being over-the-counter drugs and their pres-
ence in many drug combinations available in the pharma-
ceutical market.6 In the year 2000, diclofenac potassium
took first place in drug sales in the pharmaceutical indus-
try. This marketing information is confirmed by studies on
the use of the drug in the country, in which NSAIDs take
one of the top places in the ranking of most used drugs by
the population.7-10
In spite of the importance of NSAIDs to medical prac-
tice, the fact that they are the ones most frequently involved
in adverse reactions, and the conclusions of many Brazilian
studies regarding the indiscriminate and incorrect use of the
NSAIDs under many circumstances, there are few specific
studies about the social and medical implications of NSAIDs.
In this context, the present study is presented. It represents
the first consideration of the issue of NSAIDs use in a popu-
lation undergoing upper endoscopy in a university hospital,
in which the role of NSAIDs has been investigated in cases
of occurrence of gastric lesions. This study investigated the
association between exposure to NSAIDs and the occurrence
of gastric lesions observed during the upper endoscopy.
METHODS
This study had a cross-sectional design and was carried
out at Hospital das Clínicas of UFMG, a university hospi-
tal located in Belo Horizonte, Minas Gerais, Brazil, in the
year 2000. This hospital primarily serves citizens who use
the public health system. The project was approved by the
Ethics Committee of the Hospital (ETIC 007/2000).
Population Study
The reference population included individuals who were
17 or over and had scheduled endoscopies. Patients unable
to respond and patients undergoing specific endoscopy pro-
cedures (eg, sclerotherapy of esophageal varices, stenosis
dilation of the esophagus, pyloric obstruction, or polypec-
tomy) were excluded. A sample of 385 patients was re-
quired to obtain a 95% confidence interval of +/-5% around
a prevalence estimate of 50%. Considering a loss of 15%,
a sampling size of 445 patients would have been large
enough. However, the sample includes 582 patients who
were chosen through systematic sampling.
Data Collection
The data collection was carried out between June and
December 2000. The information was obtained through an
interview made immediately before the upper endoscopy.
A standardized questionnaire was used to collect informa-
tion about the use of NSAIDs, socio-demographic charac-
teristics, the use of alcohol and cigarettes, health problem
history, and the use of other medicines. After the interview,
the information about gastric lesions was collected from
the upper endoscopy report.
Study variables
The outcome variables were the indicators of occurrence
of gastric lesions described in the upper endoscopy report
as follows: gastric erosions, gastric erosions with hematin
pigment, and gastric ulcer (present/absent).
The use of NSAIDs during the 30 days preceding the
upper endoscopy was considered, and all the covariates re-
lated to NSAIDs referred to this interval. Information was
collected about any type of NSAID use—continuous or not,
prescribed or not—over this 30-day period. The exposure
to NSAIDs was categorized into 4 categories as follows:
1) regular use—the continuous use of NSAIDs anytime
within the 30 days before the upper endoscopy and present
at the time of the exam; 2) interrupted regular use—con-
tinuous use of NSAIDs anytime within the 30 days before
the exam but interrupted before the time of the exam; 3)
sporadic use—sporadic use of NSAIDs anytime within the
30-day period before the time of the exam; 4) non-use—
no related use NSAIDs within the 30 days studied.
Concerning the duration of the therapy, 5 categories
were defined for each type of use as follows: 1 = less than
7 days of NSAIDs use; 2 = 7 through 15 days of use; 3 =
16 through 30 days of use; 4 = 31 days through 1 year of
use; 5 = more than 1 year of use.
The sociodemographic covariates studied were gender,
age, education (in years of schooling), and individual
monthly income calculated in terms of number of minimum
salaries at the time of data collection).
The covariates related to lifestyle were the use of alco-
hol (do you consume any alcoholic beverage?) and the use
of cigarettes (do you smoke any kind of cigarettes?).
The covariate related to the morbidity history included
a previous history of peptic ulcer and/or digestive
hemorrhage.
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Concerning the use of other medicines, the regular use
of drugs prescribed or not in the last 30 days was investi-
gated, especially that of corticosteroids and anticoagulants.
Homeopathic products, and the preparation for which the
composition was not identified even after some search in
the local drugstores, were not considered.
Statistical analysis
All the covariates were categorical, and the univariate
analysis was performed using Pearson chi-squared and
Fisher exact tests. Multivariate logistic regression was used
in the multivariate analysis. All the covariates with a P
value < 0.20 in the univariate analysis were included in the
multivariate logistic model. The covariates that were asso-
ciated with NSAIDs use with a P value < 0.05 were re-
tained in the model. The magnitude of association was
measured using the odds-ratio (OR). The 95% confidence
intervals were also reported. The data analysis was done
using the software Stata, version 7.0.
RESULTS
From the 582 selected patients, 533 (91.6%) were stud-
ied. Loss of 49 patients was due to failure in carrying out
an upper endoscopy due to the patients’ intolerance. There
was however no difference in gender or age between pa-
tients who answered the questionnaire and those who did
not.
The average age of the studied patients was 49 years.
Most of them (45.8%) had between 1 and 4 years of school-
ing, and 12.6% were illiterate. Twenty-eight percent of the
patients (149) declared that they did not to have a monthly
income. Of the 384 patients (72.0%) who declared having
an individual monthly income, most received between 1
and 3 minimum salaries (US $83.93 to US $251.79). Con-
cerning lifestyles, only 18.5% of those interviewed declared
themselves to be smokers, and 35.8% used alcoholic bev-
erage.
The primary reasons for the endoscopy procedure were
as follows: gastrointestinal symptoms, 310 patients
(58.2%); treatment of digestive pathologies, 97 patients
(18.2%); and preoperative procedures, 28 patients (5.3%).
One hundred and two patients (19.1%) reported a previ-
ous history of peptic ulcer and/or digestive hemorrhage.
Most patients also reported having some kind of disease
(80.7%), especially cardiovascular diseases (22.8%) and
diseases of the skeletal-muscular system (18.3%). Concern-
ing the use of non-NSAIDs, 91 patients (17.0%) used 4 or
more drugs on a regular basis. Only 16 patients used
corticosteroids, and only 5 patients used anticoagulants.
Among those interviewed, 274 patients (51.4%) regu-
larly used at least 1 kind of non-NSAID. From the 533 stud-
ied patients, 182 (34.1%) declared the use of some kind
of NSAID during some period within the 30 days before
the interview, adding up to a total of 249 used drugs.
Among them, most (70.9%) used only one NSAID in the
studied period. However, 6.6% of the users mentioned the
use of 3 or more nonsteroidal anti-inflammatory drugs in
the period considered.
Regarding the duration of use, the highest percentage
observed was for the sporadic use and the use for a period
of less than 7 days (51.4%). On the other hand, among the
patients who reported regular use of NSAIDs, 70.7% used
some NSAID for a period greater than 15 days. The most
used drug was the acetylsalicylic acid (59.5%), followed
by the diclofenac (28.1%), and the piroxicam (2.8%).
According to the upper endoscopy report, 461 patients
(86.5%) presented some kind of alteration in the
gastrointestinal tract. Of the total number of interviewed
people, 195 (36.6%) presented gastric erosions; 29 (5.4%)
presented gastric erosions with hematinic pigment, and 21
(4.0%) received a diagnosis of gastric ulcer, which was later
confirmed by histological examination.
Table 1 shows the distribution of the NSAIDs-using pa-
tients according to the occurrence of the gastric erosions,
gastric erosions with hematin pigment, and gastric ulcer.
The table shows the estimated value and the 95% confi-
dence interval of the odds ratio (OR) for the occurrence of
each of these lesions.
As shown on Table 1, a strong and significant associa-
tion between the use of NSAIDs and the occurrence of gas-
Table 1 - Association between nonsteroidal anti-inflammatory drugs (NSAID)use and the occurrence of gastric lesions
according to univariate analysis
NSAID use Gastric erosions Odds Ratio Gastric erosions Odds Ratio Gastric ulcer Odds Ratio
95% CI with hematin 95% CI 95% CI
Absent Present Absent Present Absent Present
No 245 (72.5%) 106 (54.4%) 1.0 339 (67.3%) 12 (41.4%) 1.0 341 (66.6%) 10 (47.6%) 1.0
Yes 93 (27.5%) 89 (45.6%) 2.21 165 (32.7%) 17 (58.6%) 2.91 171 (33.4%) 11 (52.4%) 2.17
1.50-3.27 1.27-6.71 0.83-5.70
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tric lesions and gastric lesions with hematin was observed.
Concerning the occurrence of gastric ulcer, an association
was possibly present, but not statistically significant.
Considering the subsample of regular NSAIDs users, a
comparison was made between the occurrence of lesions in
patients who used NSAIDs for more than 15 days and in those
who used them for a shorter period. Table 2 shows the results
of this comparison. A positive and statistically significant as-
sociation between the use of NSAIDs for more than 15 days
and the occurrence of gastric lesions was observed.
A model including the use of NSAIDs and the other rel-
evant covariates was estimated for each outcome variable.
Table 3 presents the estimated adjusted odds ratio with the
95% confidence interval for the association between
NSAIDs use and the occurrence of each studied gastric le-
sion. The use of NSAIDs was modeled separately for each
outcome variable. Age, years of schooling, individual
monthly income, use of alcoholic beverages, previous his-
tory of ulcer and/or digestive hemorrhage, and the regular
use of other medicines were important confounding fac-
tors for the association between the use of NSAIDs and the
occurrence of gastric lesions. For the association between
the use of NSAIDs and gastric lesions with hematin, only
age and years of schooling were important confounding fac-
tors. In the case of association between the use of NSAIDs
and gastric ulcer, there was an adjustment based on the age
and on the previous history of ulcer and/or digestive
hemorrhage. As it can be seen on Table 3, the use of
NSAIDs was strongly and independently associated with
the occurrence of each of the studied lesions.
Table 4 presents the estimated odds ratio and the 95%
confidence interval for the association between the use of
NSAIDs for more than 15 days and the occurrence of the
gastric lesions. Additionally, Table 4 shows that the period
of NSAIDs use was modeled separately for each lesion of
interest. For each association, the confounding factors did
not appreciably alter the findings of the univariate analy-
sis. Therefore, for each considered lesion, the use of
NSAIDs for more than 15 days was strongly and independ-
ently associated with their occurrence.
Table 4 - Results of multivariate analysis of association between nonsteroidal anti-inflammatory drugs (NSAID) use for
more than 15 days and the occurrence of gastric lesions
Gastric erosionsa Gastric erosions with hematinb Gastric ulcerc
Unadjusted Odds Adjusted Odds Unadjusted Odds Adjusted Odds Unadjusted Odds Adjusted Odds
Ratio 95% CI Ratio95% CI Ratio95% CI Ratio95% CI Ratio95% CI Ratio95% CI
NSAID use > 15 days 8.20 7.76 5.09 5.03 6.11 6.59
4.24-16.07 3.65-16.54 2.12-12.11 2.03-12.47 2.25-16.41 2.11-20.51
a
 controlled for age, education of schooling), individual monthly income, alcohol use, previous history of ulcer or/and digestive bleeding and regular use of
another drugs. b controlled for age and education (years of schooling). c controlled for age and previous history of ulcer or/and digestive bleeding.
Table 3 - Results of multivariate analysis of association between nonsteroidal anti-inflammatory drugs use and the occurrence
of gastric lesions
Gastric erosionsa Gastric erosions with hematinb Gastric ulcerc
Unadjusted Odds Adjusted Odds Unadjusted Odds Adjusted Odds Unadjusted Odds Adjusted Odds
Ratio 95% CI Ratio95% CI Ratio95% CI Ratio95% CI Ratio95% CI Ratio95% CI
NSAID use 2.21 1.98 2.91 2.82 2.17 2.96
1.50-3.27 1.28-3.05 1.27-6.71 1.29-6.14 0.83-5.70 1.08-8.07
a
 controlled for age, education (years of schooling), individual monthly income, alcohol use, previous history of ulcer or/and digestive bleeding and regular
use of another drugs. b controlled for age and education (years of schooling). c controlled for age and previous history of ulcer or/and digestive bleeding.
Table 2 - Association between nonsteroidal anti-inflammatory drugs (NSAID) use for more than 15 days and the occurrence
of gastric lesions according to univariate analysis
NSAID use Gastric erosions Odds Ratio Gastric erosions Odds Ratio Gastric ulcer Odds Ratio
use > 15 days 95% CI with hematin 95% CI 95% CI
Absent Present Absent Present Absent Present
No* 324 (95.9%) 144 (73.8%) 1.0 450 (89.3%) 18 (62.1%) 1.0 456 (89.1%) 12 (57.1%) 1.0
Yes 14 (4.1%) 51 (26.2%) 8.20 54 (10.7%) 11 (37.9%) 5.09 56 (10.9%) 9 (42.9%) 6.11
4.24-16.07 2.12-12.11 2.25-16.41
* includes 15-day or less NSAID users and NSAID non-users.
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DISCUSSION
In Brazil, pharmacoepidemiology is still a new research
field, and the extent of the occurrence of gastrointestinal
injuries among NSAID users is poorly understood. It is
likely that this is the first study that addresses this subject,
and it will certainly support the identification of different
intervention areas. A few reports have discussed this prob-
lem under other circunstances11,12
The prevalence of the NSAIDs use in the sample was
34.0% in the investigated period. Concerning the methodo-
logical differences, a study of the use of minor analgesics and
NSAIDs by people over 18 in Sweden found a prevalence of
35.0%.13 Because NSAIDs are nonprescription drugs in Bra-
zil, are commonly used symptomatically, and are present in
a great variety of medicine combinations, a higher prevalence
would be expected. On the other hand, it is important to note
the specificity of this sample, which consisted of patients un-
dergoing upper endoscopy and who could have been warned
about the risks associated with the use of NSAIDs, during
treatment of previous gastrointestinal problems.
A discussion about the most used NSAIDs by the popu-
lation is necessary. The study findings fit well with many
other studies that have found acetylsalicylic acid and
diclofenac as the most used NSAIDs.8,14 A relevant finding
is that the 3 most used NSAIDs, which are acetylsalicylic
acid, diclofenac, and piroxicam, are among the ones that
have an intermediate-to-high level of gastrointestinal side-
effect risk.15-18 Excluding acetylsalicylic acid, which can be
used as a platelet anti-aggregator, diclofenac as well as the
piroxicam can be replaced by safer and more efficient al-
ternative drugs.
The prevalence of gastroduodenal lesions associated
with the use of the NSAIDs depends on the target popula-
tion. Studies show that about 40.0% of the individuals who
use one kind of NSAID can present gastric erosion.19 Ac-
cording to other studies, this prevalence can reach 100%,
mainly in the first month of treatment.20 In the present
study, among the individuals who mentioned some use of
NSAIDs in the investigated period, the prevalence of gas-
tric erosions reached 49%. Considering only the patients
who used NSAIDs for more than 30 days (58 individuals),
81% presented gastric erosions.
The results of the multivariate analysis show that even
after the control of covariates, the association between the
use of NSAID and the presence of gastric erosions was still
significant, with an odds ratio equal to 1.98 (95.0% IC 1.28-
3.05). Although some authors do not consider the erosions
to be precursors to gastrointestinal complications since they
hardly ever develop into ulcers,21,22 other studies show a
higher risk of gastric ulcers in patients whose diagnosis con-
firmed gastric erosions and a chronicle use of NSAIDs, in-
dependent of the prophylactic treatment.23,24 These findings
were confirmed by another study that also suggested that
the presence of erosions is a better predictor of ulceration
risk than the number of gastric erosions.25
In spite of the methodological differences between the
present study and the other ones cited, the prevalence of
81.0% of gastric erosions in long-term NSAID users sug-
gests the necessity for strict attention, so that
gastrointestinal complications such as digestive hemorrhage
or gastric ulcer can be prevented. It must be added that al-
though digestive hemorrhages more frequently develop
from ulcers, they can also develop from gastric erosions,15,26
emphasizing the significance of the prevalence of gastric
erosion found in this study.
Another controversial point is the association between
the longer period of NSAID use and the presence of gas-
tric erosions. Most authors assert that the gastric erosions
heal as time goes by and that the chronic use of NSAIDs
is accompanied by adaptation by the gastric mucous to
mitigate the harm caused by these drugs. The results of this
study support those of others that assert the variability in
the adaptation phenomenon of gastric mucous, since it does
not occur in all patients. This study also supports other stud-
ies that have evaluated endoscopic lesions in patients un-
dergoing long treatments with NSAIDs, for instance, for a
period more than 6 months, who presented a considerable
frequency of gastric lesions.25,27
Concerning the gastric erosions with hematin pigment,
no detailed literature was found, since most studies encoun-
ter them in the same context as for gastric erosions. The
occurrence of this lesion and its strong association with the
NSAID use is of concern, since these pigments generally
indicate severe harm to the mucosa that is highly associ-
ated with the topical aggression caused by the use of
NSAIDs.21 The results here presented confirm this associa-
tion through the odds ratio, which equals 2.82 (95.0% IC
1.29-6.14) after the control of covariates.
The prevalence of duodenal and/or gastric ulcers in pa-
tients using NSAIDs for more than 1 month has been re-
ported to be 5.0% to 30.0%.20 In cross-sectional studies,
this prevalence has been reported to be 14.0% to 31.0%.22
In a cross-sectional study of the impact of NSAID use on
the prevalence of peptic ulcer carried out in Finland, 16.0%
of the individuals who used NSAIDs regularly presented
this kind of pathology.28 In the present study the patients
who regularly used NSAIDs (n = 58) presented a preva-
lence of gastric ulcer of 32.7%.
This study showed an association between the regular
use of NSAIDs and the presence of gastric ulcers with an
odds ratio equal to 2.96 (95.0% IC 1.08-8.07). Most re-
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searchers describe the relative risk of gastric ulcer in
NSAID users of about 3.0 or more.16,28 Regarding a time
of use greater than 30 days, the association was demon-
strated by an odds ratio equal to 7.11 (95.0% IC 2.28-22.13)
in the present study. Although this result shows that the
more an individual uses NSAIDs, the higher the chance of
gastric ulcer, which is in agreement with other investiga-
tions, this odds ratio must be interpreted cautiously. The
confidence interval is wide, probably due to the low preva-
lence of gastric ulcer and the risk factor, ie, the use of
NSAIDs for a period greater than 1 month (4.0% and
10.9%, respectively).
Although the focus of this study was on the associa-
tion between the use of NSAIDs and the presence of gas-
tric lesions, it is important to note the behavior of some of
the covariates. Age was an important confounding factor
for the association of NSAIDs use and the occurrence of
gastric erosions and gastric ulcers, but gender was not a
confounding factor. Although income has not been men-
tioned in the literature as a confounding factor for the as-
sociation of the NSAID use and the occurrence of gastric
lesions, income was found to be a confounding factor in
the present study. Individuals whose income was equal to
or higher than 3 minimum salaries were more likely to use
NSAIDs as well as to have gastric erosions.
Previous history of ulcers and/or digestive hemorrhage,
known as a confounding factor in the association between
the use of NSAID and gastric erosions and gastric ulcers,
showed a significant independent association with these le-
sions. It is important to emphasize that among the patients
with a previous history of peptic ulcer/digestive hemorrhage,
the use of NSAIDs was significantly less than among those
without such a history, which would be expected.
The use of alcohol has also been considered important
as a confounding factor for the association between the use
of NSAID and gastric erosions. However, for the gastric
ulcer, this association was not statistically significant.
Smoking was also shown not to be a confounding factor.
Since this was an exploratory study, the use of alcohol and
cigarettes was not quantified, although the quantity used
could affect the occurrence of gastric erosions. Conse-
quently, lack of quantitation could also have influenced the
research results.
The regular use of other drugs was a confounding fac-
tor for the association of NSAID use and the gastric ero-
sions. A possible explanation for this behavior is, on one
hand, that the NSAIDs are found in many situations of
polypharmacy.29,30 On the other hand, a higher number of
drugs may mean a higher level of population morbidity or
even the existence of concomitant chronic diseases that in
some circumstances increase the individual’s risk for
gastrointestinal problems.31-33 The importance of the con-
comitant use of corticosteroids and anticoagulants with
NSAIDs and the potential increase in the risk of
gastrointestinal lesions and the complications of these le-
sions is emphasized in the literature.31-33 This relationship
could not be investigated in this study, because the use of
these drugs occurred infrequently (16 and 5 patients, re-
spectively), which limited the power of the study to analyze
these covariates. In general, these findings point to a ne-
cessity of a national and wider study, evaluating the inter-
relations among these factors and the use of NSAIDs, as
well as the occurrence of gastric lesions.
Another limitation in this study is the fact that the as-
sociation between infection by Helicobacter pylori and the
studied lesions as a possible interfering factor in the asso-
ciation between the use of NSAID and the mentioned le-
sions was not studied, since not all the patients underwent
tests to detect the infection. Since the test was not randomly
assigned, it is possible that there were some differences
between the group undergoing the test and the group that
did not. Further study is necessary to better comprehend
this relationship.
Considering methodological aspects, the procedures
were standardized to avoid bias. The internal validity of
the study is ensured by the small sample loss. From the
epidemiological point of view, the main limitation of the
study is the fact that the results are not strong enough to
make an inference about the general population. On the
other hand, the study’s findings follow some tendencies
described in literature as previously presented.
The study showed that, after controlling for age, indi-
vidual monthly income, schooling, use of alcohol, smok-
ing, previous history of ulcers and/or digestive hemorrhage,
and regular use of other drugs, the use of NSAIDs is an
independent factor associated with the occurrence of gas-
tric erosions and gastric ulcers. In spite of the limitations
of the transversal design, it is possible that the duration of
drug use was one of the most important risk factors.
It is important to emphasize that the findings of this
study are from a setting of a university hospital, an excel-
lence center in Brazil, which almost guarantees that the in-
terviewed patients had already used other services in the
same hospital and probably had received safer and better
prescriptions and drug-use orientation than the population
that goes to other health institutions in the country.
Based on the results found, a concern about the use of
NSAIDs remains, as well as its consequences with respect
to other Brazilian scenarios. It is reasonable to accept that
a considerable percentage of the gastric lesions found could
have been avoided, provided that preventive measures to
stimulate the rational use of the drugs had been taken.
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RESUMO
Ribeiro AQ, Sevalho G, César C. Uso de antiinflamatórios
não-esteróides e ocorrência de lesões gástricas entre paci-
entes submetidos à endoscopia digestiva alta em Hospital
Universitário no Brasil. CLINICS. 2006;61(5): 409-16.
INTRODUÇÃO: No Brasil são bastante evidentes os ris-
cos associados ao uso de medicamentos. No entanto, tal
questão não é devidamente privilegiada no campo da in-
vestigação científica. O presente estudo se refere ao uso
de antiinflamatórios não-esteróides, fármacos amplamente
utilizados no país. O objetivo foi investigar o uso de
antiinflamatórios não-esteróides entre pacientes submeti-
dos à endoscopia digestiva alta no Hospital das Clínicas
da Universidade Federal de Minas Gerais e sua associação
com a ocorrência de erosões gástricas, erosões gástricas
com pigmento de hematina e úlcera gástrica.
MÉTODOS: Estudo transversal em que 533 pacientes com
idade igual ou superior a 17 anos foram entrevistados no
período de junho a dezembro de 2000. Os dados foram sub-
metidos às análises bivariada e multivariada.
RESULTADOS: Mais de dois terços da população entre-
vistada relatou o uso de antiinflamatórios não-esteróides no
período de um mês anterior à endoscopia digestiva alta. Os
antiinflamatórios mais utilizados foram o ácido acetil-
salicílico e o diclofenaco. Evidenciou-se uma associação
positiva e significativa entre o uso desses fármacos e a ocor-
rência das lesões em questão. Ao se avaliar a associação entre
o uso de antiinflamatórios não-esteróides por um período
superior a 15 dias e a ocorrência das lesões gástricas, esta
foi positiva e significativa, apresentado odds ratio superio-
res àqueles apresentados para as associações anteriores.
CONCLUSÕES: Os resultados sugerem que os antiinfla-
matórios não-esteróides têm uma associação significativa
com a ocorrência de lesões gástricas e apontam para a ne-
cessidade de aprofundamento no estudo desta questão no
Brasil.
UNITERMOS: Farmacoepidemiologia. Antiinflamatórios
não-esteróides. Endoscopia digestiva alta. Reações adver-
sas a medicamentos.
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